liver fibrosis

EDINBURGH and LONDON, UK — September 11, 2026 Resolution Therapeutics Limited announced that the final patient has been treated...

Daix, France and New York, September 2, 2026 Inventiva announced that the last patient has completed the final 72-week...

GAITHERSBURG, Md., Aug. 3, 2026 Altimmune, Inc. has initiated patient enrollment in the global PERFORMA Phase 3 registrational trial...

INDIANAPOLIS, Ind., June 18, 2026 Elanco Animal Health Incorporated has announced plans to establish Elanco Ventures, a dedicated corporate...

SINGAPORE and SEOUL, South Korea, June 17, 2026 D&D Pharmatech and HistoIndex have announced encouraging new findings from an...

NEW ORLEANS, June 8, 2026 insitro announced new preclinical findings from its lead metabolic dysfunction-associated steatohepatitis (MASH) program, demonstrating...

LONDON, UK, May 28, 2026 GSK has announced groundbreaking Phase III clinical trial results for bepirovirsen, its investigational antisense...

SEATTLE and SINGAPORE, May 27, 2026 Callio Therapeutics has announced the presentation of its Phase 1 clinical trial design...

BASEL, Switzerland, May 27, 2026 Roche has announced the launch of its groundbreaking Liver Disease Panel, the healthcare industry’s...

CAMBRIDGE, Mass., May 20, 2026 MetaVia Inc. has announced the publication of new peer-reviewed preclinical research supporting the anti-fibrotic...